170 related articles for article (PubMed ID: 17229867)
61. Evaluation of the BD Phoenix automated system for determining antimicrobial susceptibility against carbapenem-resistant Enterobacteriaceae compared with broth microdilution.
Haffler ZJ; Kulengowski B; Ribes JA; Burgess DS
Int J Antimicrob Agents; 2019 Aug; 54(2):249-254. PubMed ID: 31071467
[TBL] [Abstract][Full Text] [Related]
62. Accuracy of cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway System.
Biedenbach DJ; Marshall SA; Jones RN
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):305-7. PubMed ID: 10212758
[No Abstract] [Full Text] [Related]
63. [Antibiotic susceptibility and occurrence of ESBL, IBL and MBL in Pseudomonas aeruginosa strains].
Wolska K; Jakubczak A; Soszyńska A
Med Dosw Mikrobiol; 2008; 60(2):111-9. PubMed ID: 18819447
[TBL] [Abstract][Full Text] [Related]
64. Erroneous reporting of vancomycin susceptibility for Staphylococcus spp. by Vitek software version 2.01.
Behera B; Mathur P
Jpn J Infect Dis; 2009 Jul; 62(4):298-9. PubMed ID: 19628909
[TBL] [Abstract][Full Text] [Related]
65. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
[TBL] [Abstract][Full Text] [Related]
66. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
Kim SY; Hong SG; Moland ES; Thomson KS
J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
[TBL] [Abstract][Full Text] [Related]
67. [Evaluation of the Phoenix system for identifying and determining the susceptibility of clinical isolates. Comparative study with the Microscan system].
Marco F; Jurado A; Jiménez de Anta MT
Rev Esp Quimioter; 2004 Jun; 17(2):169-76. PubMed ID: 15470511
[TBL] [Abstract][Full Text] [Related]
68. Comparison of BD phoenix to vitek 2, microscan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae.
Mittman SA; Huard RC; Della-Latta P; Whittier S
J Clin Microbiol; 2009 Nov; 47(11):3557-61. PubMed ID: 19741088
[TBL] [Abstract][Full Text] [Related]
69. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Honderlick P; Gravisse J; Dardelle D; Cahen P
Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
[TBL] [Abstract][Full Text] [Related]
70. Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.
Färber J; Moder KA; Layer F; Tammer I; König W; König B
J Clin Microbiol; 2008 Nov; 46(11):3721-7. PubMed ID: 18845821
[TBL] [Abstract][Full Text] [Related]
71. Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms.
Fritsche TR; Rennie RP; Goldstein BP; Jones RN
J Clin Microbiol; 2006 Aug; 44(8):2988-90. PubMed ID: 16891523
[TBL] [Abstract][Full Text] [Related]
72. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin.
Tan TY; Ng SY
Clin Microbiol Infect; 2007 May; 13(5):541-4. PubMed ID: 17371537
[TBL] [Abstract][Full Text] [Related]
73. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
74. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance.
Sinirtaş M; Akalin H; Gedikoğlu S
Int J Infect Dis; 2009 Sep; 13(5):e217-20. PubMed ID: 19230734
[TBL] [Abstract][Full Text] [Related]
75. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.
Yamano Y; Nishikawa T; Fujimura T; Yutsudou T; Tsuji M; Miwa H
J Antibiot (Tokyo); 2006 Dec; 59(12):791-6. PubMed ID: 17323646
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae.
Carroll KC; Glanz BD; Borek AP; Burger C; Bhally HS; Henciak S; Flayhart D
J Clin Microbiol; 2006 Oct; 44(10):3506-9. PubMed ID: 17021074
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus.
Malaviolle X; Nonhoff C; Denis O; Rottiers S; Struelens MJ
J Antimicrob Chemother; 2008 Nov; 62(5):1018-23. PubMed ID: 18765413
[TBL] [Abstract][Full Text] [Related]
78. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
79. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
[TBL] [Abstract][Full Text] [Related]
80. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
